Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote 2026-09-16 5-day change 1st Jan Change
17.21 CNY -0.12% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. -5.02% -8.31%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.81B 1.17B 1.01B 954M 866M 1.62B 112B 1.63B 11.39B 4.4B 56.69B 4.38B 4.28B 181B P/E 2026 *
18.7x
P/E 2027 * 15.6x
Enterprise Value 8.32B 1.24B 1.07B 1.02B 922M 1.73B 119B 1.74B 12.12B 4.69B 60.33B 4.66B 4.55B 192B EV / Sales 2026 *
2.22x
EV / Sales 2027 * 1.94x
Free-Float
51.96%
Yield 2026 *
1.99%
Yield 2027 * 2.86%
08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-09 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-27 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
25-10-29 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
25-10-24 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-14 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
25-06-13 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
25-04-30 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
1 day-0.12%
1 week-5.02%
Current month-0.52%
1 month-10.60%
3 months+8.38%
6 months-12.55%
Current year-8.31%
1 week 16.91
Extreme 16.91
18.02
1 month 16.59
Extreme 16.59
19.59
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
22.96
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-29
Director of Finance/CFO 51 2022-04-27
Corporate Officer/Principal 45 2020-10-26
Director TitleAgeSince
Chairman 63 2008-05-11
Director/Board Member 53 2019-12-24
Director/Board Member 51 2020-01-09
Date Insider Type Main position Quantity % Market Cap. Importance
5/24/23 Buy 3,000 0.0009%
5/23/23 Buy 1,000 0.0003%
9/4/20 Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-5.02%-21.70%-6.67% 1.17B
-0.59%-0.76%-50.09%-59.50% 30.34B
-0.61%-4.63%+22.64%+90.66% 11.49B
+0.36%-5.56%-13.95%0.00% 3.81B
-0.95%-1.27%-1.73%+19.54% 3.05B
-0.68%-6.52%+31.63%+22.60% 1.9B
+0.58%+1.77%+12.18%+34.12% 1.86B
+0.77%-5.39%-10.70%+179.71% 1.42B
-0.39%+12.31%-7.23%-8.57% 1.02B
-0.89%-7.64%-11.33%-43.45% 1.02B
Average -0.21%-1.27%-5.03%+22.84% 5.71B
Weighted average by Cap. -0.27%-1.38%-22.69%-7.06%

Financials

2026 *2027 *
Net sales 3.74B 557M 483M 456M 414M 777M 53.47B 781M 5.45B 2.11B 27.12B 2.09B 2.05B 86.44B 4.2B 626M 543M 513M 466M 873M 60.08B 878M 6.12B 2.37B 30.47B 2.35B 2.3B 97.13B
Net income 428M 63.87M 55.35M 52.31M 47.49M 89.01M 6.13B 89.54M 624M 241M 3.11B 240M 235M 9.91B 512M 76.34M 66.16M 62.53M 56.77M 106M 7.32B 107M 747M 288M 3.71B 287M 280M 11.84B
Net Debt 503M 74.94M 64.94M 61.38M 55.72M 104M 7.19B 105M 733M 283M 3.65B 281M 275M 11.62B 339M 50.51M 43.77M 41.37M 37.56M 70.39M 4.85B 70.81M 494M 191M 2.46B 190M 186M 7.83B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
26-09-16 CN¥17.21 -0.12% 4,675,924
26-09-15 CN¥17.23 -0.58% 2,827,300
26-09-14 CN¥17.33 +0.58% 3,648,176
26-09-11 CN¥17.23 -3.31% 3,950,400
26-09-10 CN¥17.82 -0.78% 3,479,976
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
17.21CNY
Average target price
21.06CNY
Spread / Average Target
+22.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!